Pharmaceutical Manufacturing – Methocarbamol Tablets

The contract entails the manufacture and supply of 4,000 bottles, each containing 500 tablets of Methocarbamol 0.5 GRAM, fully compliant with United States Pharmacopeia standards, current Good Manufacturing Practices, and a mandatory 24-month shelf-life requirement. This is a subcontract under the Department of Defense’s Medical Supply Chain Pharm FSA, with performance obligated at Fort Stewart, Georgia, under ZIP code 31314-5185. The solicitation, identified by the number SPE2DP26T3326 and classified under NAICS code 325412 for pharmaceutical preparation manufacturing, was posted on May 10, 2026, with a firm response deadline of May 18, 2026. All supplied tablets must meet rigorous quality and stability benchmarks to ensure safety, efficacy, and regulatory alignment for government use, with no set-aside provisions specified for small or minority-owned businesses.